TORONTO, ONTARIO--(Marketwired - Sept. 14, 2016) - Apogee Silver Ltd. ("Apogee" or the "Company") (TSX VENTURE:APE) announces that it has changed its name to Apogee Opportunities Inc. effective September 16, 2016. The Company will continue to trade on the TSX Venture Exchange un...Read More
TORONTO, ONTARIO--(Marketwired - Sep 14, 2016) - Apogee Silver Ltd. ("Apogee" or the "Company") (TSX VENTURE:APE) announces that it has changed its name to Apogee Opportunities Inc. effective September 16, 2016. The Company will continue to trade on the TSX Venture Exchange under the symbol...Read More
TORONTO, ONTARIO--(Marketwired - Oct. 13, 2016) - Apogee Opportunities Inc. ("Apogee" or the "Company") (TSX VENTURE:APE) announces that Mr. Francois Perron has stepped down from the Board of Directors of the Company to focus on other endeavours. Fred Leigh, CEO and Director of...Read More
TORONTO, ONTARIO--(Marketwired - Oct 13, 2016) - Apogee Opportunities Inc. ("Apogee" or the "Company") (TSX VENTURE:APE) announces that Mr. Francois Perron has stepped down from the Board of Directors of the Company to focus on other endeavours. Fred Leigh, CEO and Director of the Company,...Read More
ANNAPOLIS, Md., March 14, 2017 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results for the year ended December 31, 2016. Fourth quarter and subsequent operational highlight...Read More
(TheNewswire) Toronto, ON / TheNewswire / April 21, 2017 - At the request of IIROC, Alturas Minerals Corp. wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity. Alturas Mine...Read More
GAITHERSBURG, Md., May04, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT) announced today the completion of its merger with PharmAthene, Inc., effective May 4, 2017. Upon the completion of the merger, the combined company was renamed Altimmune, Inc., and will commence trading on The NASDAQ C...Read More
GAITHERSBURG, Md., May16, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced the promotion of Sybil Tasker, M.D., FACP, FIDSA, to the position of Chief Medical Officer.Dr. Tasker joined the company in April 2016 as Senior Vice Presid...Read More
GAITHERSBURG, Md., June19, 2017(GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that Bill Enright, President and Chief Executive Officer of Altimmune, will present a corporate overview at the BIO International Convention, taking place...Read More
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 21, 2017) - ALTAIR RESOURCES INC. ("Altair" or the "Company") (TSX VENTURE:AVX)(FRANKFURT:90A) (ISIN: CA02137W1014) (WKN: WKN A2ALMP) President and CEO, Mr. Harold (Roy) Shipes, is pleased to announce that the Company has acquire...Read More
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 25, 2017) - ALTAIR RESOURCES INC. ("Altair" or the "Company") (TSX VENTURE:AVX)(FRANKFURT:90A) (ISIN: CA02137W1014) (WKN: WKN A2ALMP) - Mr. Harold (Roy) Shipes, President and CEO, is pleased to announce that the Company has acquired a Lease and...Read More
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 31, 2017) - ALTAIR RESOURCES INC. ("Altair" or the "Company") (TSX VENTURE:AVX)(FRANKFURT:90A) (ISIN: CA02137W1014) (WKN: WKN A2ALMP) Mr. Harold (Roy) Shipes, President and CEO, is pleased to announce that Altair has intersected exc...Read More
VANCOUVER, June 2, 2017 /CNW/ - ALTAIR RESOURCES INC. ("Altair" or the "Company") (TSXV: AVX; Germany FRA: 90A; ISIN: CA02137W1014; WKN: WKN A2ALMP) Mr. Roy Shipes, President and CEO, announces the resignation of Mr. Robert Naso as Chief Financial Officer of the Company and the appointment o...Read More
VANCOUVER, June 9, 2017 /CNW/ - ALTAIR RESOURCES INC. ("Altair" or the "Company") (TSXV: AVX; Germany FRA: 90A; ISIN: CA02137W1014; WKN: WKN A2ALMP) Mr. Harold (Roy) Shipes, President and CEO, is pleased to announce that Altair has received its overlimit zinc assays for the six samples previous...Read More
VANCOUVER, BC--(Marketwired - April 10, 2017) - Almadex Minerals Limited ("Almadex" or the "Company") (TSX VENTURE: AMZ) (OTCQB: AXDDF) is pleased to announce it has received assay results from channel samples taken in the newly discovered Raya Tembrillo area of outcropping porphyry gold-copper...Read More